2026 ICD-10-CM Diagnosis Code T46.2X1SPoisoning by other antidysrhythmic drugs, accidental (unintentional), sequela

ICD-10-CM CodesS00–T88T36-T50T46

ICD-10-CM T46.2X1S
CMSSource: CMS FY 2026 ICD-10-CM dataset · Effective Oct 1, 2025 – Sep 30, 2026

T46.2X1S is a billable ICD-10-CM diagnosis code for poisoning by other antidysrhythmic drugs, accidental (unintentional), sequela. The 7th character S marks it as a sequela code, which reports a problem that remains after the original condition has resolved. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRG 922 through 923. The code is exempt from POA reporting. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Poisoning/toxic effect/adverse effects/underdosing, sequela.

Code Identity

ICD-10-CM Code
T46.2X1S
Billable Status
Yes — Valid for Submission
Code Describes
Poisoning by other antidysrhythmic drugs, accidental (unintentional), sequela
Short Description
Poisoning by oth antidysrhythmic drugs, accidental, sequela
Parent Code
Poisoning by other antidysrhythmic drugs, accidental (unintentional)

Code Classification

ChapterS00–T88Injury, poisoning and certain other consequences of external causes
SectionT36-T50Poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances
CategoryT46Poisoning by, adverse effect of and underdosing of agents primarily affecting the cardiovascular system
This CodeT46.2X1SPoisoning by other antidysrhythmic drugs, accidental (unintentional), sequela

Present on Admission (POA)Billing

T46.2X1S is exempt from POA reporting on inpatient claims to general acute care hospitals. Review other POA exempt codes.

Approximate SynonymsGuidance

Alternate terms and clinical phrases that map to this code.

  • Accidental amiodarone overdose
  • Accidental amiodarone poisoning
  • Accidental bretylium overdose
  • Accidental disopyramide overdose
  • Accidental disopyramide poisoning
  • Accidental poisoning by quaternary ammonium derivatives
  • Accidental procainamide overdose
  • Accidental procainamide poisoning
  • Accidental quinidine overdose
  • Accidental quinidine poisoning
  • Amiodarone overdose
  • Amiodarone poisoning
  • Bretylium overdose
  • Class II antiarrhythmic overdose
  • Class III antiarrhythmic overdose
  • Disopyramide overdose
  • Disopyramide poisoning
  • Overdose of cardiac antiarrhythmic agent
  • Poisoning by procainamide
  • Poisoning by quinidine
  • Procainamide overdose
  • Quinidine overdose

Coding GuidelinesGuidance

When coding a poisoning or reaction to the improper use of a medication (e.g., overdose, wrong substance given or taken in error, wrong route of administration), first assign the appropriate code from categories T36-T50. The poisoning codes have an associated intent as their 5th or 6th character (accidental, intentional self-harm, assault and undetermined). If the intent of the poisoning is unknown or unspecified, code the intent as accidental intent. The undetermined intent is only for use if the documentation in the record specifies that the intent cannot be determined. Use additional code(s) for all manifestations of poisonings.

The appropriate 7th character is to be added to each code from block Poisoning by, adverse effect of and underdosing of agents primarily affecting the cardiovascular system (T46). Use the following options for the applicable episode of care:

  • A - initial encounter
  • D - subsequent encounter
  • S - sequela

Source: ICD-10-CM Official Guidelines for Coding and Reporting, FY 2026, published by CMS and the National Center for Health Statistics.

Clinical ClassificationClinical

AHRQ’s CCSR groups this code into broader clinical categories.

CCSR INJ075
Poisoning/toxic effect/adverse effects/underdosing, sequela
Default principal diagnosis: inpatient Yes · outpatient Yes

Clinical InformationClinical

  • Ajmaline

    an alkaloid found in the root of rauwolfia serpentina, among other plant sources. it is a class 1-a antiarrhythmic agent that apparently acts by changing the shape and threshold of cardiac action potentials.
  • Amiodarone

    an antianginal and class iii antiarrhythmic drug. it increases the duration of ventricular and atrial muscle action by inhibiting potassium channels and voltage-gated sodium channels. there is a resulting decrease in heart rate and in vascular resistance.
  • Aprindine

    a class ib anti-arrhythmia agent used to manage ventricular and supraventricular arrhythmias.
  • Bunaftine

    n-butyl-n-(2-(diethylamino)ethyl)-1-naphthamide. a proposed antiarrhythmic that prolongs myocardial refractory period and stabilizes cell membranes.
  • Disopyramide

    a class i anti-arrhythmic agent (one that interferes directly with the depolarization of the cardiac membrane and thus serves as a membrane-stabilizing agent) with a depressant action on the heart similar to that of guanidine. it also possesses some anticholinergic and local anesthetic properties.
  • Encainide

    one of the anti-arrhythmia agents, it blocks voltage-gated sodium channels and slows conduction within the his-purkinje system and myocardium.
  • Flecainide

    a potent anti-arrhythmia agent, effective in a wide range of ventricular and atrial arrhythmias and tachycardias.
  • Lorajmine

    a monochloroacetyl derivative of ajmaline. it is a class ia antiarrhythmic agent that is rapidly hydrolyzed to ajmaline by plasma and tissue esterases.
  • Mexiletine

    antiarrhythmic agent pharmacologically similar to lidocaine. it may have some anticonvulsant properties.
  • Procainamide

    a class ia antiarrhythmic drug that is structurally-related to procaine.
  • Propafenone

    an antiarrhythmia agent that is particularly effective in ventricular arrhythmias. it also has weak beta-blocking activity.
  • Quinidine

    an optical isomer of quinine, extracted from the bark of the chinchona tree and similar plant species. this alkaloid dampens the excitability of cardiac and skeletal muscles by blocking sodium and potassium currents across cellular membranes. it prolongs cellular action potentials, and decreases automaticity. quinidine also blocks muscarinic and alpha-adrenergic neurotransmission.
  • Tocainide

    an antiarrhythmic agent which exerts a potential- and frequency-dependent block of sodium channels.

Table of Drugs and ChemicalsClinical

Substances in the Table of Drugs and Chemicals that reference this code family. Always confirm in the Tabular List before coding.

SubstanceAccidentalSelf-harmAssaultUndeter­minedAdverse
Effect
Under­dosing
Adenosine (phosphate)T46.2X1T46.2X2T46.2X3T46.2X4T46.2X5T46.2X6
AjmalineT46.2X1T46.2X2T46.2X3T46.2X4T46.2X5T46.2X6
AmiodaroneT46.2X1T46.2X2T46.2X3T46.2X4T46.2X5T46.2X6
Antidysrhythmic NECT46.2X1T46.2X2T46.2X3T46.2X4T46.2X5T46.2X6
AprindineT46.2X1T46.2X2T46.2X3T46.2X4T46.2X5T46.2X6
Bretylium tosilateT46.2X1T46.2X2T46.2X3T46.2X4T46.2X5T46.2X6
BunaftineT46.2X1T46.2X2T46.2X3T46.2X4T46.2X5T46.2X6
CardiacT46.2X1T46.2X2T46.2X3T46.2X4T46.2X5T46.2X6
Cardiac::depressantsT46.2X1T46.2X2T46.2X3T46.2X4T46.2X5T46.2X6
Cardiac::rhythm regulatorT46.2X1T46.2X2T46.2X3T46.2X4T46.2X5T46.2X6
Cardiac::rhythm regulator::specified NECT46.2X1T46.2X2T46.2X3T46.2X4T46.2X5T46.2X6
Chinidin (e)T46.2X1T46.2X2T46.2X3T46.2X4T46.2X5T46.2X6
CibenzolineT46.2X1T46.2X2T46.2X3T46.2X4T46.2X5T46.2X6
DisopyramideT46.2X1T46.2X2T46.2X3T46.2X4T46.2X5T46.2X6
EncainideT46.2X1T46.2X2T46.2X3T46.2X4T46.2X5T46.2X6
FlecainideT46.2X1T46.2X2T46.2X3T46.2X4T46.2X5T46.2X6
HydroquinidineT46.2X1T46.2X2T46.2X3T46.2X4T46.2X5T46.2X6
LorajmineT46.2X1T46.2X2T46.2X3T46.2X4T46.2X5T46.2X6
LorcainideT46.2X1T46.2X2T46.2X3T46.2X4T46.2X5T46.2X6
MexiletineT46.2X1T46.2X2T46.2X3T46.2X4T46.2X5T46.2X6
Pilsicainide (hydrochloride)T46.2X1T46.2X2T46.2X3T46.2X4T46.2X5T46.2X6
Prajmalium bitartrateT46.2X1T46.2X2T46.2X3T46.2X4T46.2X5T46.2X6
ProcainamideT46.2X1T46.2X2T46.2X3T46.2X4T46.2X5T46.2X6
Pronestyl (hydrochloride)T46.2X1T46.2X2T46.2X3T46.2X4T46.2X5T46.2X6
PropafenoneT46.2X1T46.2X2T46.2X3T46.2X4T46.2X5T46.2X6
QuinagluteT46.2X1T46.2X2T46.2X3T46.2X4T46.2X5T46.2X6
QuinidineT46.2X1T46.2X2T46.2X3T46.2X4T46.2X5T46.2X6
TocainideT46.2X1T46.2X2T46.2X3T46.2X4T46.2X5T46.2X6

Patient EducationClinical

Medication Errors

Medicines treat infectious diseases, prevent problems from chronic diseases, and ease pain. But medicines can also cause harmful reactions if not used correctly. Errors can happen in the hospital, at the health care provider's office, at the pharmacy, or at home. You can help prevent errors by:

Read the full article at MedlinePlus

Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.

Convert T46.2X1S to ICD-9-CMHistory

The closest ICD-9-CM equivalents under the General Equivalence Mappings.

ICD-9-CM
909.0 Late eff drug poisoning
ApproximateCombination The match is approximate, and more than one code can be needed to describe the source diagnosis. Confirm with contextual judgment.
ICD-9-CM
E929.2 Late eff acc poisoning
ApproximateCombination The match is approximate, and more than one code can be needed to describe the source diagnosis. Confirm with contextual judgment.

Code HistoryHistory

FY 2016AddedAdded to the ICD-10-CM code setEffective October 1, 2015, the first year of ICD-10-CM.
FY 2017–2025No changes
FY 2026CurrentCurrent code set, no changesEffective October 1, 2025 through September 30, 2026.

Questions About T46.2X1SOverview

Is T46.2X1S a billable code?

Yes. This is a billable ICD-10-CM code, specific enough to report poisoning by other antidysrhythmic drugs, accidental (unintentional), sequela on HIPAA-covered claims from October 1, 2025 through September 30, 2026.

What does the 7th character S in T46.2X1S mean?

The final character S makes this a sequela code: it reports a lingering problem that remains after the poisoning by other antidysrhythmic drugs, accidental (unintentional) itself has resolved, not the original event.

What MS-DRG does T46.2X1S group to?

When poisoning by other antidysrhythmic drugs, accidental (unintentional), sequela is the principal diagnosis on an inpatient stay, it groups to MS-DRG 922, 923, with relative weights from 1.0177 to 1.7494 depending on complications. Higher weights mean higher Medicare reimbursement.

Is T46.2X1S exempt from POA reporting?

Yes. CMS lists this code among those exempt from present on admission reporting, so hospitals do not assign a POA indicator for poisoning by other antidysrhythmic drugs, accidental (unintentional), sequela on inpatient claims.

What is the ICD-9 equivalent of T46.2X1S?

Under the General Equivalence Mappings, poisoning by other antidysrhythmic drugs, accidental (unintentional), sequela converts to ICD-9-CM 909.0 (late eff drug poisoning) and E929.2 (late eff acc poisoning). The mapping is approximate, so confirm the match fits the documentation.

Footnotes

[1] Not chronic - A diagnosis code that does not fit the criteria for chronic condition (duration, ongoing medical treatment, and limitations) is considered not chronic. Some codes designated as not chronic are acute conditions. Other diagnosis codes that indicate a possible chronic condition, but for which the duration of the illness is not specified in the code description (i.e., we do not know the condition has lasted 12 months or longer) also are considered not chronic.